Qavi A, et al.
Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study. Infection Control and Hospital Epidemiology
2005; 26: 63–68.
Cosgrove SE. Evidence that prevention makes cents: costs of catheter-associated bloodstream infections in the intensive care unit. Critical Care Medicine
2006; 34: 2243–2244.
Klevens RM, et al.
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clinical Infectious Diseases
2006; 42: 389–391.
MacPherson DW, et al.
Population mobility, globalization, and antimicrobial drug resistance. Emerging Infectious Diseases
2009; 15: 1727–1732.
Rogers BA, et al.
Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clinical Infectious Diseases
2011; 53: 49–56.
Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990–1998. Journal of Infectious Diseases
2000; 182: 1503–1510.
Byrd TL, Law JG. Cross-border utilization of health care services by United States residents living near the Mexican border. Revista Panamericana de Salud Publica
2009; 26: 95–100.
de Guzman GC, et al.
A survey of the use of foreign-purchased medications in a border community emergency department patient population. Journal of Emergency Medicine
2007; 33: 213–221.
Fishbein D, et al.
Public health surveillance using emergency medical service logs – U.S.–Mexico land border, El Paso, Texas, 2009. Morbidity and Mortality Weekly Report
2010; 59: 649–653.
Rivera JO, et al.
Study of methicillin-resistant Staphylococcus aureus on the U.S./Mexico border. Travel Medicine and Infectious Disease
2009; 7: 30–34.
O'Brien FG, et al.
Survey of methicillin-resistant Staphylococcus aureus strains from two hospitals in El Paso, Texas. Journal of Clinical Microbiology
2005; 43: 2969–2972.
Weinberg M, et al.
The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillance. Emerging Infectious Diseases
2003; 9: 97–102.
Sanchez GV, et al.
In Vitro Antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrobial Agents and Chemotherapy
2012; 56: 2181–2183.
Johnson L, et al.
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. American Journal of Medicine
2008; 121: 876–884.
National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control
2004; 32: 470–485.
Fridkin SK, et al.
Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine
2005; 352: 1436–1444.
Hersh AL, et al.
National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Archives of Internal Medicine
2008; 168: 1585–1591.
Seybold U, et al.
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases
2006; 42: 647–656.
Burton DC, et al.
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. Journal of the American Medical Association
2009; 301: 727–736.
Landrum ML, et al.
Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. Journal of the American Medical Association
2012; 308: 50–59.
Diekema DJ, et al.
Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clinical Infectious Diseases
2004; 38: 78–85.
Hidron AI, et al.
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology
2008; 29: 996–1011.
Kyaw MH, et al.
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine
2006; 354: 1455–1463.
Beall BW, et al.
Shifting genetic structure of invasive serotype 19A pneumococci in the United States. Journal of Infectious Diseases
2011; 203: 1360–1368.
Nyquist AC, et al.
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. Journal of the American Medical Association
1998; 279: 875–877.
Peláez-Ballestas I, et al.
Use of antibiotics in upper respiratory infections on patients under 16 years old in private ambulatory medicine. Salud Publica de Mexico
2003; 45: 159–164.
Kallen AJ, Welch HG, Sirovich BE. Current antibiotic therapy for isolated urinary tract infections in women. Archives of Internal Medicine
2006; 166: 635–639.
Gagliotti C, et al.
Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples. Clinical Microbiology and Infection
2007; 13: 328–331.
Ortega AN, et al.
Health care access, use of services, and experiences among undocumented Mexicans and other Latinos. Archives of Internal Medicine
2007; 167: 2354–2360.
Yong D, et al.
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and Chemotherapy
2009; 53: 5046–5054.
Dreser A, et al.
Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health
2012; 12: 1051.